Which has the lower trailing P/E, CME or MRSH?

CME has the lower trailing P/E: CME trades at 22.71 and MRSH at 23.19. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CME or MRSH?

Over the past five years, MRSH grew revenue faster — CME at a 7.99% CAGR versus MRSH at 8.62%.

Does CME or MRSH pay a bigger dividend?

CME yields 1.42% and MRSH yields 1.90% based on trailing dividends and the latest price.

Is CME or MRSH more profitable?

CME runs the higher net margin — CME at 63.08% versus MRSH at 14.24%.

How have CME and MRSH total returns compared?

Over the past 10 years, CME delivered 14.16% and MRSH delivered 13.06% annualized total return. Past performance doesn't predict future results.

CME Group Inc. (CME) vs Marsh & McLennan Companies, Inc. (MRSH)

A side-by-side comparison of CME Group Inc. and Marsh & McLennan Companies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

CME

CME Group Inc.

$96.29B

$267.79Financial ServicesAt close: Jul 31, 2026, 4:00 PM ET

MRSH

Marsh & McLennan Companies, Inc.

$90.52B

$189.69Financial ServicesAt close: Jul 31, 2026, 4:00 PM ET

Total return — CME vs MRSH

growth of $100 · dividends reinvested · last 24y

CME +5895.2%MRSH +589.2%CME compounded faster

Log scale — wide-divergence pair

CME MRSH

CME vs MRSH: by the numbers

•CME is the larger company ($96.29B vs $90.52B market cap).
•CME trades at the lower trailing earnings multiple (22.71 vs 23.19 P/E), one valuation lens rather than an overall verdict.
•CME converts more revenue to profit (63.08% vs 14.24% net margin).
•MRSH grew revenue faster over the past five years (8.62% vs 7.99% CAGR).
•MRSH pays the higher dividend yield (1.90% vs 1.42%).

Metrics side by side

Valuation

Metric	CME	MRSH
P/E ratio	22.71	23.19
Forward P/E	21.85	18.16
P/S ratio	14.32	3.29
P/B ratio	3.66	6.05
PEG ratio	1.59	7.85

Profitability

Metric	CME	MRSH
Gross margin	81.89%	42.38%
Operating margin	65.10%	21.62%
Net margin	63.08%	14.24%
ROE	16.11%	26.21%
ROIC	1.62%	12.12%

Dividends

Metric	CME	MRSH
Dividend yield	1.42%	1.90%
Payout ratio	33.99%	42.45%

Growth (annualized)

Metric	CME	MRSH
Revenue CAGR (5Y)	7.99%	8.62%
EPS CAGR (5Y)	13.72%	16.34%
Total return CAGR (5Y)	8.74%	6.84%

Frequently asked

Which has the lower trailing P/E, CME or MRSH?: CME has the lower trailing P/E: CME trades at 22.71 and MRSH at 23.19. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CME or MRSH?: Over the past five years, MRSH grew revenue faster — CME at a 7.99% CAGR versus MRSH at 8.62%.
Does CME or MRSH pay a bigger dividend?: CME yields 1.42% and MRSH yields 1.90% based on trailing dividends and the latest price.
Is CME or MRSH more profitable?: CME runs the higher net margin — CME at 63.08% versus MRSH at 14.24%.
How have CME and MRSH total returns compared?: Over the past 10 years, CME delivered 14.16% and MRSH delivered 13.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CME analysis Full MRSH analysis Interactive comparison tool

Dig into the metrics

CME P/E ratio Marsh & McLennan Companies P/E ratio CME dividend yield Marsh & McLennan Companies dividend yield CME ROE Marsh & McLennan Companies ROE CME operating margin Marsh & McLennan Companies operating margin CME revenue growth Marsh & McLennan Companies revenue growth CME free cash flow Marsh & McLennan Companies free cash flow

CME & Marsh & McLennan Companies appear in these rankings

Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.